Literature DB >> 18495195

E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter.

Ulla Krüppel1, Andreas Müller-Schiffmann, Stephan E Baldus, Sigrun Smola-Hess, Gertrud Steger.   

Abstract

In addition to cellular transcription factors, the E2 protein encoded by human papillomaviruses (HPV) modulates the viral gene expression to support the life cycle of HPV, which depends on the differentiation of the infected keratinocytes. The role of E2 as activator of viral transcription still remains unsolved. We show here that low amounts of E2 encoded by HPV16 efficiently activated the early promoter P(97) of HPV16. In addition to the long control region, this activation required high amounts of the cellular co-activator p300 and a novel binding site for CCAAT enhancer-binding protein alpha (C/EBPalpha) located downstream of the P(97) at position 480. The expression of C/EBPalpha was shown previously to increase during keratinocyte differentiation. By immunohistochemistry we demonstrate that the expression of p300 is induced in suprabasal epithelial cells of HPV16 positive and negative squamous epithelium. Our data suggest that high levels of p300 and C/EBPalpha in suprabasal layers of HPV16 positive cervical lesions allow the viral E2 protein to activate HPV16 early gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495195     DOI: 10.1016/j.virol.2008.04.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo.

Authors:  Natalie Leiprecht; Ekaterina Notz; Johanna Schuetz; Juliane Haedicke; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

2.  Association Between Potentially Functional Variants in chr5q14 and the Risk of Cervical Cancer in a Chinese Population.

Authors:  Yuqing Liu; Ling Mei; Yueyue Chen; Xiaoli Zhang; Dongmei Wei; Tao Cui; Yueting Zhang; Tao Wang; Xiaoyu Niu
Journal:  Reprod Sci       Date:  2022-07-18       Impact factor: 2.924

3.  Acetylation of conserved lysines in bovine papillomavirus E2 by p300.

Authors:  Edward J Quinlan; Sara P Culleton; Shwu-Yuan Wu; Cheng-Ming Chiang; Elliot J Androphy
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

4.  Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes.

Authors:  Monika Oldak; Radoslaw B Maksym; Tanya Sperling; Moshe Yaniv; Hans Smola; Herbert J Pfister; Jacek Malejczyk; Sigrun Smola
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

5.  Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability.

Authors:  Xiaoyu Wang; Samisubbu R Naidu; Francis Sverdrup; Elliot J Androphy
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

Review 6.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

7.  HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation.

Authors:  Eric Ramírez-Salazar; Federico Centeno; Karen Nieto; Armando Valencia-Hernández; Mauricio Salcedo; Efraín Garrido
Journal:  Virol J       Date:  2011-05-20       Impact factor: 4.099

Review 8.  Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle.

Authors:  Megan Burley; Sally Roberts; Joanna L Parish
Journal:  Semin Immunopathol       Date:  2020-01-09       Impact factor: 9.623

9.  Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.

Authors:  Elaine J Gauson; Brad Windle; Mary M Donaldson; Maria M Caffarel; Edward S Dornan; Nicholas Coleman; Pawel Herzyk; Scott C Henderson; Xu Wang; Iain M Morgan
Journal:  Virology       Date:  2014-08-16       Impact factor: 3.616

10.  HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome.

Authors:  I J Groves; E L A Knight; Q Y Ang; C G Scarpini; N Coleman
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.